Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome.

To determine the prevalence and potential diagnostic relevance of autoantibodies against serotonin, thromboplastin, and ganglioside Gm1 in patients with fibromyalgia syndrome (FM).

Saved in:

Bibliographic Details
Main Authors:	Werle, Egon (Author) , Fischer, Heinrich P. (Author) , Müller, Annette (Author) , Fiehn, Walter (Author) , Eich, Wolfgang (Author)
Format:	Article (Journal)
Language:	English
Published:	March 1, 2001
In:	The journal of rheumatology Year: 2001, Volume: 28, Issue: 3, Pages: 595-600
ISSN:	1499-2752
Online Access:	Verlag, lizenzpflichtig, Volltext: https://www.jrheum.org/content/28/3/595
Author Notes:	Egon Werle, Heinrich P. Fischer, Annette Müller, Walter Fiehn, and Wolfgang Eich

Description
Summary:	To determine the prevalence and potential diagnostic relevance of autoantibodies against serotonin, thromboplastin, and ganglioside Gm1 in patients with fibromyalgia syndrome (FM).
Item Description:	Gesehen am 21.01.2022
Physical Description:	Online Resource
ISSN:	1499-2752